Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome

Contrast-Enhanced Spectral Mammography (CESM) is a recently introduced mammographic method with characteristics particularly suitable for breast cancer radiomic analysis. This work aims to evaluate radiomic features for predicting histological outcome and two cancer molecular subtypes, namely Human...

Full description

Bibliographic Details
Main Authors:	Daniele La Forgia, Annarita Fanizzi, Francesco Campobasso, Roberto Bellotti, Vittorio Didonna, Vito Lorusso, Marco Moschetta, Raffaella Massafra, Pasquale Tamborra, Sabina Tangaro, Michele Telegrafo, Maria Irene Pastena, Alfredo Zito
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Diagnostics
Subjects:	breast cancer histological outcome Her2 positive triple negative radiomic analysis correlation
Online Access:	https://www.mdpi.com/2075-4418/10/9/708

Similar Items

Radiomic Feature Reduction Approach to Predict Breast Cancer by Contrast-Enhanced Spectral Mammography Images
by: Raffaella Massafra, et al.
Published: (2021-04-01)

A Proposal of Quantum-Inspired Machine Learning for Medical Purposes: An Application Case
by: Domenico Pomarico, et al.
Published: (2021-02-01)

A Clinical Decision Support System for Predicting Invasive Breast Cancer Recurrence: Preliminary Results
by: Raffaella Massafra, et al.
Published: (2021-03-01)

A ultrasound-based radiomic approach to predict the nodal status in clinically negative breast cancer patients
by: Samantha Bove, et al.
Published: (2022-05-01)

A Roadmap towards Breast Cancer Therapies Supported by Explainable Artificial Intelligence
by: Nicola Amoroso, et al.
Published: (2021-05-01)

Machine learning survival models trained on clinical data to identify high risk patients with hormone responsive HER2 negative breast cancer
by: Annarita Fanizzi, et al.
Published: (2023-05-01)

Development and Validation of an Ultrasound-Based Radiomics Nomogram for Identifying HER2 Status in Patients with Breast Carcinoma
by: Yinghong Guo, et al.
Published: (2022-12-01)

Disease-Free Survival after Breast Conservation Therapy vs. Mastectomy of Patients with T1/2 Breast Cancer and No Lymph Node Metastases: Our Experience
by: Annarita Fanizzi, et al.
Published: (2021-10-01)

Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer
by: Chunli Li, et al.
Published: (2021-08-01)

Revolutionizing HER-2 assessment: multidimensional radiomics in breast cancer diagnosis
by: Hui Xie, et al.
Published: (2025-02-01)

Radiogenomic analysis of prediction HER2 status in breast cancer by linking ultrasound radiomic feature module with biological functions
by: Hao Cui, et al.
Published: (2023-01-01)

Sentinel Lymph Node Metastasis on Clinically Negative Patients: Preliminary Results of a Machine Learning Model Based on Histopathological Features
by: Annarita Fanizzi, et al.
Published: (2021-11-01)

Elite VABB 13G: A New Ultrasound-Guided Wireless Biopsy System for Breast Lesions. Technical Characteristics and Comparison with Respect to Traditional Core-Biopsy 14–16G Systems
by: Daniele La Forgia, et al.
Published: (2020-05-01)

Accurate Evaluation of Feature Contributions for Sentinel Lymph Node Status Classification in Breast Cancer
by: Angela Lombardi, et al.
Published: (2022-07-01)

Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results
by: Meiying Yan, et al.
Published: (2024-02-01)

Preliminary study on DCE-MRI radiomics analysis for differentiation of HER2-low and HER2-zero breast cancer
by: Liang Yin, et al.
Published: (2024-08-01)

Ultrasound-based radiomics nomogram for predicting HER2-low expression breast cancer
by: Xueling Zhang, et al.
Published: (2024-09-01)

A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification
by: Raffaella Massafra, et al.
Published: (2022-01-01)

A machine learning ensemble approach for 5- and 10-year breast cancer invasive disease event classification.
by: Raffaella Massafra, et al.
Published: (2022-01-01)

Multiparametric MRI-based radiomic nomogram for predicting HER-2 2+ status of breast cancer
by: Haili Wang, et al.
Published: (2024-05-01)

Development and external validation of a radiomics model for assessment of HER2 positivity in men and women presenting with gastric cancer
by: Huiping Zhao, et al.
Published: (2023-02-01)

Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer
by: Shuai Ge, et al.
Published: (2022-09-01)

A radiomics-based interpretable machine learning model to predict the HER2 status in bladder cancer: a multicenter study
by: Zongjie Wei, et al.
Published: (2024-10-01)

Radiomics signatures for predicting the Ki-67 level and HER-2 status based on bone metastasis from primary breast cancer
by: Hongxiao Zhang, et al.
Published: (2024-01-01)

The Value of Predicting Human Epidermal Growth Factor Receptor 2 Status in Adenocarcinoma of the Esophagogastric Junction on CT-Based Radiomics Nomogram
by: Shuxing Wang, et al.
Published: (2021-10-01)

A multiphase contrast-enhanced CT radiomics model for prediction of human epidermal growth factor receptor 2 status in advanced gastric cancer
by: Tingting Ma, et al.
Published: (2022-10-01)

Contrast-enhanced computed tomography-based radiomics nomogram for predicting HER2 status in urothelial bladder carcinoma
by: Jiao Peng, et al.
Published: (2024-08-01)

Early prediction of neoadjuvant chemotherapy response by exploiting a transfer learning approach on breast DCE-MRIs
by: Maria Colomba Comes, et al.
Published: (2021-07-01)

Identifying factors that may influence the classification performance of radiomics models using contrast-enhanced mammography (CEM) images
by: Yuqi Sun, et al.
Published: (2022-05-01)

The impact of harmonization on radiomic features in Parkinson’s disease and healthy controls: A multicenter study
by: Benedetta Tafuri, et al.
Published: (2022-10-01)

Value of CT-Based Radiomics in Predicating the Efficacy of Anti-HER2 Therapy for Patients With Liver Metastases From Breast Cancer
by: Miao He, et al.
Published: (2022-04-01)

Radiomics Analysis in Ovarian Cancer: A Narrative Review
by: Francesca Arezzo, et al.
Published: (2021-08-01)

Radiomics Integration of Mammography and DCE-MRI for Predicting Molecular Subtypes in Breast Cancer Patients
by: Yang X, et al.
Published: (2025-02-01)

Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
by: Raffaella Massafra, et al.
Published: (2023-02-01)

Evaluation of Epidermal Growth Factor Receptor 2 Status in Gastric Cancer by CT-Based Deep Learning Radiomics Nomogram
by: Xiao Guan, et al.
Published: (2022-07-01)

Intratumoral and peritumoral ultrasound-based radiomics for preoperative prediction of HER2-low breast cancer: a multicenter retrospective study
by: Siwei Luo, et al.
Published: (2025-03-01)

Radiomic features of breast parenchyma: assessing differences between FOR PROCESSING and FOR PRESENTATION digital mammography
by: Mario Sansone, et al.
Published: (2021-10-01)

Radiomics and Artificial Intelligence Analysis with Textural Metrics Extracted by Contrast-Enhanced Mammography in the Breast Lesions Classification
by: Roberta Fusco, et al.
Published: (2021-04-01)

Radiomic Analysis of Contrast-Enhanced Mammography With Different Image Types: Classification of Breast Lesions
by: Simin Wang, et al.
Published: (2021-05-01)

Radiomics Based on Digital Mammography Helps to Identify Mammographic Masses Suspicious for Cancer
by: Guangsong Wang, et al.
Published: (2022-04-01)